Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer-Reference-Cited by-同舟云学术

Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer

Published:2019-10-08 Issue:3 Volume:50 Page:292-297
ISSN:0941-1291
Container-title:Surgery Today
language:en
Short-container-title:Surg Today

Author:

Sekido Yuki,Nishimura Junichi,Fujino Shiki,Ogino Takayuki,Miyoshi Norikatsu,Takahashi Hidekazu,Uemura Mamoru,Haraguchi Naotsugu,Hata Taishi,Matsuda Chu,Mizushima Tsunekazu,Murata Kohei,Hasegawa Junichi,Mori Masaki,Doki Yuichiro

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00595-019-01886-7.pdf

Reference20 articles.

1. Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, et al. Japanese society for cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015;20:207–39.

2. Kusters M, Beets GL, van de Velde CJ, Beets-Tan RG, Marijnen CA, Rutten HJ, et al. Acomparison between the treatment of low rectal cancer in Japan and the Netherkands, focucing on the patterns of locul recurrence. Ann Surg. 2009;249:229–35.

3. Kim JC, Takahashi K, Yu CS, Kim HC, Kim TW, Ryu MH, et al. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Ann Surg. 2007;246:754–62.

4. Hasegawa J, Nishimura J, Mizushima T, Miyake Y, Kim HM, Takemoto H, et al. Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer. Cancer Chemother Pharmacol. 2014;73:1079–87.

5. Nishimura J, Hasegawa J, Kato T, Yoshioka S, Noura S, Kagawa Y, et al. Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer. Cancer Chemother Pharmacol. 2018;82:707–16.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Positron Emission Tomography (PET) for Distinguishing Metastatic Lymph Nodes from Nonmetastatic Among Patients with Rectal Cancer: A Systematic Review and Meta-Analysis;World Journal of Nuclear Medicine;2024-08-06

2. Successfully Resected Isolated Lateral Lymph Node Recurrence in a Patient with T1 Lower Rectal Cancer: Case Report and Literature Review;Journal of the Anus, Rectum and Colon;2024-07-25

3. Research on the low rectal cancer complicated with lateral pelvic lymph node metastasis from literature;Asian Journal of Surgery;2024-07

4. Risk factors for lateral pelvic lymph node metastasis in patients with lower rectal cancer: a systematic review and meta-analysis;Frontiers in Oncology;2023-09-06

5. Robotic versus laparoscopic approach for minimally invasive lateral pelvic lymph node dissection of advanced lower rectal cancer: a retrospective study comparing short-term outcomes;Techniques in Coloproctology;2023-05-08